Literature DB >> 25156736

Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract.

Megan M Jones1, Antoinette Johnson2, Mary Koszelak-Rosenblum3, Charmaine Kirkham2, Aimee L Brauer2, Michael G Malkowski3, Timothy F Murphy4.   

Abstract

Moraxella catarrhalis is a strict human pathogen that causes otitis media in children and exacerbations of chronic obstructive pulmonary disease in adults, resulting in significant worldwide morbidity and mortality. M. catarrhalis has a growth requirement for arginine; thus, acquiring arginine is important for fitness and survival. M. catarrhalis has a putative oligopeptide permease ABC transport operon (opp) consisting of five genes (oppB, oppC, oppD, oppF, and oppA), encoding two permeases, two ATPases, and a substrate binding protein. Thermal shift assays showed that the purified recombinant substrate binding protein OppA binds to peptides 3 to 16 amino acid residues in length regardless of the amino acid composition. A mutant in which the oppBCDFA gene cluster is knocked out showed impaired growth in minimal medium where the only source of arginine came from a peptide 5 to 10 amino acid residues in length. Whether methylated arginine supports growth of M. catarrhalis is important in understanding fitness in the respiratory tract because methylated arginine is abundant in host tissues. No growth of wild-type M. catarrhalis was observed in minimal medium in which arginine was present only in methylated form, indicating that the bacterium requires l-arginine. An oppA knockout mutant showed marked impairment in its capacity to persist in the respiratory tract compared to the wild type in a mouse pulmonary clearance model. We conclude that the Opp system mediates both uptake of peptides and fitness in the respiratory tract.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156736      PMCID: PMC4249328          DOI: 10.1128/IAI.02185-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

Review 1.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 2.  Blocking NO synthesis: how, where and why?

Authors:  Patrick Vallance; James Leiper
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

3.  Plasmid pWW115, a cloning vector for use with Moraxella catarrhalis.

Authors:  Wei Wang; Eric J Hansen
Journal:  Plasmid       Date:  2006-06-06       Impact factor: 3.466

4.  An aerosol challenge mouse model for Moraxella catarrhalis.

Authors:  W G Hu; J Chen; F M Collins; X X Gu
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

Review 5.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  OppA of Listeria monocytogenes, an oligopeptide-binding protein required for bacterial growth at low temperature and involved in intracellular survival.

Authors:  E Borezee; E Pellegrini; P Berche
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 7.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

Review 8.  Moraxella catarrhalis: a review of an important human mucosal pathogen.

Authors:  R Karalus; A Campagnari
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

Review 9.  The burden of otitis media.

Authors:  J O Klein
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

10.  Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children.

Authors:  Patricia Stutzmann Meier; Simone Freiburghaus; Andrea Martin; Nadja Heiniger; Rolf Troller; Christoph Aebi
Journal:  Pediatr Infect Dis J       Date:  2003-03       Impact factor: 2.129

View more
  22 in total

Review 1.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

2.  The oppD Gene and Putative Peptidase Genes May Be Required for Virulence in Mycoplasma gallisepticum.

Authors:  Chi-Wen Tseng; Chien-Ju Chiu; Anna Kanci; Christine Citti; Renate Rosengarten; Glenn F Browning; Philip F Markham
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

3.  Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Michael E Pichichero
Journal:  Vaccine       Date:  2017-07-26       Impact factor: 3.641

Review 4.  Bacterial peptide transporters: Messengers of nutrition to virulence.

Authors:  Preeti Garai; Kasturi Chandra; Dipshikha Chakravortty
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

5.  Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.

Authors:  Antonia C Perez; Antoinette Johnson; Ziqiang Chen; Gregory E Wilding; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

6.  Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2015-09-21       Impact factor: 3.641

7.  A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Antoinette Johnson; Gregory E Wilding; Mary Koszelak-Rosenblum; Michael G Malkowski
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

8.  Oligopeptide-binding protein from nontypeable Haemophilus influenzae has ligand-specific sites to accommodate peptides and heme in the binding pocket.

Authors:  Kari J Tanaka; Heather W Pinkett
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

Review 9.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

10.  The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.

Authors:  Taketo Otsuka; Charmaine Kirkham; Aimee Brauer; Mary Koszelak-Rosenblum; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.